Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 48 entries
View as:

Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT06827587 Org: User:
Start: 02/28/25 End: 12/31/26 Due: 12/31/27

Early and Late Prognosis in Patients With Guillain-Barre Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06041451 Org: User:
Start: 01/02/13 End: 01/31/25 Due: 01/31/26

Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）

Phase: N/A Priority: Normal
NCT ID: NCT06368882 Org: User:
Start: 01/01/24 End: 12/31/28 Due: 12/31/29

Positive Psychological Intervention for Parkinson's Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT06832358 Org: User:
Start: 02/01/22 End: 04/01/23 Due: 04/01/24

Feasibility of Simplified Permanent Left Bundle Branch Pacing Without Electrophysiological Recording System

Phase: N/A Priority: Normal
NCT ID: NCT05553431 Org: User:
Start: 09/30/22 End: 12/31/23 Due: 12/31/24

The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT04273529 Org: User:
Start: 02/20/20 End: 06/30/20 Due: 06/30/21

Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic Therapies

Phase: N/A Priority: Normal
NCT ID: NCT05448222 Org: User:
Start: 07/01/22 End: 12/01/24 Due: 12/01/25

A Metal Bare Stent With 125 Iodine （125I）Seeds for the Treatment of Malignant Central Airway Stenosis

Phase: N/A Priority: Normal
NCT ID: NCT03944408 Org: User:
Start: 05/31/19 End: 02/28/22 Due: 02/28/23

The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT06041412 Org: User:
Start: 02/01/12 End: 01/02/25 Due: 01/02/26

The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases

Phase: N/A Priority: Normal
NCT ID: NCT06420154 Org: User:
Start: 05/27/24 End: 05/27/27 Due: 05/27/28

Safety and Effectiveness of Left Bundle Branch Pacing in Patients With Cardiac Dysfunction and AV Block

Phase: N/A Priority: Normal
NCT ID: NCT05553626 Org: User:
Start: 09/30/22 End: 02/28/25 Due: 02/28/26

Predicting Complications of Hepatolithiasis After Hepatectomy

Phase: N/A Priority: Normal
NCT ID: NCT05556434 Org: User:
Start: 07/01/11 End: 07/01/24 Due: 07/01/25

Fecal Microbiota Transplantation in Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT04591522 Org: User:
Start: 10/15/20 End: 06/30/22 Due: 06/30/23

Tislelizumab Plus Chemotherapy as Postoperative Adjuvant Therapy in Elderly Patients With LA GC/GEJC

Phase: N/A Priority: Normal
NCT ID: NCT06238167 Org: User:
Start: 04/01/24 End: 12/31/28 Due: 12/31/29

Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03110640 Org: User:
Start: 10/01/16 End: 09/30/21 Due: 09/30/22

mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05200299 Org: User:
Start: 02/01/22 End: 06/30/25 Due: 06/30/26

Effect of a WeChat Platform-based Management Intervention on Blood Pressure Control

Phase: N/A Priority: Normal
NCT ID: NCT04682015 Org: User:
Start: 02/18/21 End: 12/31/22 Due: 12/31/23

Assessing Diabetic Foot Ulcer Microcirculation With High-frequency Contrast Enhanced Ultrasound

Phase: N/A Priority: Normal
NCT ID: NCT06309082 Org: User:
Start: 11/30/24 End: 12/31/26 Due: 12/31/27

Intensive Insulin for Severe/Moderate Hypertriglyceridemia Pancreatitis.

Phase: N/A Priority: Normal
NCT ID: NCT03501680 Org: User:
Start: 06/06/18 End: 12/31/20 Due: 12/31/21

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular Endothelial Growth Factor Monoclonal Antibody vs Immune Checkpoint Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT06119347 Org: User:
Start: 01/01/20 End: 10/10/23 Due: 10/10/24

Effectiveness and Safety of Danshen Injection for Acute Kidney Injury in Primary Nephrotic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06071533 Org: User:
Start: 01/01/12 End: 10/03/23 Due: 10/03/24

Autologous CARTmeso/19 Against Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03497819 Org: User:
Start: 10/01/17 End: 10/31/20 Due: 10/31/21

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

Phase: N/A Priority: Normal
NCT ID: NCT05828953 Org: User:
Start: 09/28/21 End: 12/31/26 Due: 12/31/27

Relationship Between Liver Cancer and Sarcopenia

Phase: N/A Priority: Normal
NCT ID: NCT05339919 Org: User:
Start: 05/01/20 End: 08/28/25 Due: 08/28/26

Identification and Verification of Neutrophil Extracellular Trap Net Related Markers in Acute-on-chronic Liver Failure

Phase: N/A Priority: Normal
NCT ID: NCT05909319 Org: User:
Start: 06/25/23 End: 06/25/25 Due: 06/25/26